BioLargo's BEST Expands Industrial PFAS Treatment Activities Amid Major PFAS Settlements
Two paid industrial pilots build on extensive New Jersey municipal installation resultsPFAS settlements underscore financial ...
Model output · Signal date 2026-11-06
Biolargo, Inc. (BLGO) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Rating · 90D
Unlock rating and forecasts
90-day forecast
Sign up free to reveal
30-day forecast
Alpha
Rank in coverage
of 5150 stocks scored
Rank correlation · 90D
-14.0%
Spearman, 357 dates
Market Cap
$26M
small-cap · #15 of 17 peers
Summary
Biolargo, Inc. (BLGO) stock forecast summary
Our AI scores Biolargo, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
Biolargo, Inc. is a small-cap company with a market capitalization of $26M. It ranks number 15 by market capitalization among the 17 Chemicals & Allied Products issuers in our coverage with a current forecast.
For BLGO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -14.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -5.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BLGO included.
Price
BLGO price chart and AI forecast
Cross-section · 2026-11-06
How BLGO ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals · 2026-06-30
Biolargo, Inc. (BLGO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Chemicals & Allied Products peers listed below that report each metric.
Valuation & Market
| Metric | BLGO | Rank |
|---|---|---|
| Market Cap | $26M | 15/17 |
| Revenue/Share | $0.01 | – |
Profitability & Margins
| Metric | BLGO | Rank |
|---|---|---|
| ROA | -234.7% | 12/13 |
| Gross Margin | 45.3% | 3/14 |
| Operating Margin | -504.1% | 10/12 |
| Net Margin | -435.5% | 11/12 |
| EBT Margin | -513.8% | 13/14 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | BLGO | Rank |
|---|---|---|
| Current Ratio | 0.73x | 15/16 |
| Quick Ratio | 0.67x | 13/13 |
| Interest Coverage | -13.1x | 10/14 |
| Working Capital | -$1M | 15/16 |
Cash Flow
| Metric | BLGO | Rank |
|---|---|---|
| Operating Cash Flow | -$13M | 15/15 |
Operational Efficiency
| Metric | BLGO | Rank |
|---|---|---|
| Asset Turnover | 0.61x | 8/13 |
| Receivables Turnover | 5.6x | 7/10 |
| Inventory Turnover | 8.1x | 3/13 |
| Fixed Assets Turnover | 2.3x | 8/13 |
| Days Sales Outstanding | 65 days | 4/10 |
| Days Inventory | 45 days | 11/13 |
| Payables Period | 130 days | 2/10 |
| Cash Conversion Cycle | -20 days | 6/7 |
Income Statement
| Metric | BLGO | Rank |
|---|---|---|
| Total Revenue | $4M | 10/13 |
| Operating Income | -$18M | 9/13 |
| Net Income | -$16M | 8/13 |
| R&D Expense | $3M | 8/10 |
| SG&A Expense | $13M | 11/13 |
| Cost of Goods Sold | $2M | 12/14 |
Dividend & Shareholder Information
| Metric | BLGO | Rank |
|---|---|---|
| Shares Outstanding | 329M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $4M | |
| Cash & Short-term Investments | $2M | |
| Accounts Receivable | $720K | |
| Inventory | $300K | |
| Total Liabilities | $9M | |
| Short-term Debt | $4M |
Quarterly Financial Reports
BLGO quarterly financials and insider trading
Industry Peers · Chemicals & Allied Products
Biolargo, Inc. (BLGO) industry peers
Companies classified under the same SEC industry code as Biolargo, Inc. (Chemicals & Allied Products): 17 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| BLGO Biolargo, Inc. | $26M | |
| BCPC Balchem Corp | $5.54B | |
| PRM Perimeter Group Inc. | $4.83B | |
| NGVT Ingevity Corp | $2.07B | |
| OLN Olin Corp | $1.97B | |
| IOSP Innospec Inc. | $1.93B | |
| CC Chemours Co | $1.92B | |
| HUN Huntsman Corp | $1.64B | |
| ECVT Ecovyst Inc. | $1.15B | |
| FMC Fmc Corp | $876M | |
| SLI Standard Lithium Ltd. | $360M | |
| ADUR Aduro Clean Technologies Inc. | $358M | |
| ACNT Ascent Industries Co. | $124M | |
| LQMT Liquidmetal Technologies Inc | $64M | |
| CITR Citrotech Inc. | $53M | |
| LOOP Loop Industries, Inc. | $12M | |
| GURE Gulf Resources, Inc. | $6M |
Where BLGO sits on the market map
Industrial Applications and Services · Chemicals & Allied Products
News
Biolargo, Inc. (BLGO) stock news
BioLargo's Clyra Medical Gains Commercial Traction as Clinician Enthusiasm Drives Health System Adoption
Following a strong reception at SAWC Fall 2026, Clyra and BioLargo leadership discuss clinician feedback, health system ...
BioLargo, Inc. (BLGO) Q4 2025 Earnings Call Transcript
Good afternoon, everyone, and thank you for your patience. Welcome to the BioLargo 2025 Annual Report and Earnings Call. [Operator Instructions] Please note, this conference is being recorded. I will ...
FAQ
Biolargo, Inc. (BLGO) stock forecast FAQ
What is the Biolargo, Inc. (BLGO) stock forecast?
Our AI scores Biolargo, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are Biolargo, Inc. stock predictions?
For BLGO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -14.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -5.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Biolargo, Inc. forecasts updated?
Biolargo, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are Biolargo, Inc.'s industry peers?
17 issuers in our coverage, BLGO included, share the SEC industry code Chemicals & Allied Products. The largest are: Balchem Corp (BCPC), Perimeter Group Inc. (PRM), Ingevity Corp (NGVT), Olin Corp (OLN), Innospec Inc. (IOSP), Chemours Co (CC).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.